CLINICAL_TRIALS
research
· 2017-03-03
Clinical Trial Update: Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
Summary
Clinical trial update on mesenchymal stromal cells for adults with Recessive Dystrophic Epidermolysis Bullosa (Phase 1/Phase 2).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: King's College London | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 1, Phase 2 | Status: UNKNOWN